THERE HAS BEEN controversy regarding the appropriate use of magnetic resonance (MR) contrast agents in the evaluation of central nervous system (CNS) tumors. When MR imaging was first available in clinical practice in the early 1980s. contrast agents were thought to be unnecessary because of the exc
Pitfalls of contrast-enhanced imaging in the nervous system
β Scribed by Michael Brant-Zawadzki
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 449 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
This brief review covers the evolving clinical role of paramagnetic contrast agents in magnetic resonance imaging of the central nervous system, with particular emphasis on potential pitfalls. The safety and efficacy of GdβDTPA is now wellβestablished. Approximately 35β40% of all scans performed in this country now utilize the agent. The major pitfalls center on overinterpretation of the characterization of disease by either enhancement or lack thereof in any particular process. Β© 1991 Academic Press, Inc.
π SIMILAR VOLUMES
MAGNETIC RESONANCE (MR) imaging has become the modality of choice for evaluating the peripheral nervous system (PNS), since MR imaging has shown a high sensitivity for detecting a variety of mechanical (compression and entrapment), inflammatory, neoplastic, and traumatic lesions. The sensitivity of
## Abstract A group of 70 professional divers and 47 healthy control subjects who had never dived were examined with magnetic resonance (MR) imaging to determine the prevalence of focal white matter changes in the brain. Spots of high signal intensity in white matter on proton densityβand/or T2βwei
Gadolinium-DTPA has been shown to be a good probe for demonstrating defects in the blood-brain barrier, but it has a rapid rate of elimination so that peak circulating levels are short-lived. In this study ultrafast echo-planar imaging has been used in combination with a bolus injection of gadoliniu
## Abstract The soβcalled βKety modelβ is a twoβcompartment pharmacokinetic model describing tumor perfusion kinetics. Its parameters, the transendothelial transfer constant (__K__^__trans__^), extravascular extracellular volume fraction (Ο ~__e__~), and microvascular plasma volume fraction (Ο ~__p__